ArticleFrontiers in cellular and infection microbiology2026
Identification and characterization of new B cell epitopes on the nucleocapsid protein of bovine coronavirus using monoclonal antibodies.
Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bovine coronavirus (BCoV) is an important pathogen that causes diarrhea in calves, winter dysentery in adult cattle and respiratory diseases, causing significant economic losses to the global cattle industry. N protein is the most conserved structural protein of coronavirus, with strong immunogenicity and serving as an ideal target for early diagnosis and vaccine development. In this study, the prokaryotic expression system was used to express the recombinant BCoV N protein and used it as an immunogen to immunize BALB/c mice. Two specific monoclonal antibodies (mAbs) against BCoV N protein, 4D8 and 6F3, were successfully generated through hybridoma technology. Western blotting and IFA results demonstrated that both mAbs can react specifically with BCoV and have good reactivity and specificity. Isotype identification revealed that both monoclonal antibodies belong to the IgG1 isotype. By constructing a series of truncated N protein fragments and subsequent western blot analysis, the linear B cell epitopes recognized by these mAbs were precisely mapped. The research results showed that the mAb 4D8 can identify the epitope spanning
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.